Fertility Preservation

Koichi Kyono

doi:10.1274/jmor.30.101

We can help you reset your password using the email address linked to your BioOne Complete account.

Registered users receive a variety of benefits including the ability to customize email alerts, create favorite journals list, and save searches. Please note that a BioOne web account does not automatically grant access to full-text content. An institutional or society member subscription is required to view non-Open Access content. Contact helpdesk@bioone.org with any questions.

All Fields are Required

First Name

Last/Family Name

Password

Password Requirements: Minimum 8 characters, must include as least one uppercase, one lowercase letter, and one number or permitted symbol Valid Symbols for password:
~ Tilde
! Exclamation Mark
@ At sign
$ Dollar sign
^ Caret
( Opening Parenthesis
) Closing Parenthesis
_ Underscore
. Period

Confirm Password

Web Account created successfully

Koichi Kyono^1,*

¹Kyono ART Clinic, 1-1-1, Miyagi, 980-0014, Japan

^*To whom correspondence should be addressed, e-mail: info@ivf-kyono.or.jp

Abstract

Oocyte, embryo, ovarian tissue, and sperm cryopreservation before cancer treatments (aggressive chemotherapy/radiotherapy and bone marrow transplantation) are useful for the fertility preservation of cancer patients.This paper discusses the importance of the available treatment options including the risks, advantages and disadvantages of fertility preservation options. The reimplantation of contaminated ovarian tissue could be a life-threatening event. Therefore, the detection of minimal residual disease (MRD) is also discussed. Key words: Fertility preservation, Cryopreservation, Cancer, Pregnancy, Minimal residual disease (MRD) is also discussed.

Citation Download Citation

Koichi Kyono "Fertility Preservation," Journal of Mammalian Ova Research 30(3), 101-108, (1 October 2013). https://doi.org/10.1274/jmor.30.101

Received: 19 June 2013; Accepted: 1 July 2013; Published: 1 October 2013